Pfizer

Allen Waxman, senior vice president and general counsel at Pfizer, is leaving the company for personal reasons. Mr. Waxman will remain outside counsel to Pfizer through a transition period. David Reid, currently senior vice president and managing director, will assume Mr. Waxman’s responsibilities on an interim basis until the company finds a permanent successor.
   
“Allen and his team have been strong advocates for Pfizer, securing a number of important legal decisions that are significant for our business and our future,” said Jeff Kindler, chairman and chief executive officer. “Allen has provided valuable counsel not only on legal matters but on our overall business strategy and the issues facing Pfizer in its operating environment. He has made many contributions to our company. We thank him for those contributions and wish him well in his future endeavors.”